loadpatents
name:-0.063631057739258
name:-0.031492948532104
name:-0.010612010955811
WENDT; Michael D. Patent Filings

WENDT; Michael D.

Patent Applications and Registrations

Patent applications and USPTO patent grants for WENDT; Michael D..The latest application filed is for "apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases".

Company Profile
11.39.65
  • WENDT; Michael D. - Vernon Hills IL
  • Wendt; Michael D - Vernon Hills IL
  • Wendt; Michael D. - North Chicago IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210346369 - WANG; Le ;   et al.
2021-11-11
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210228565 - Wang; Le ;   et al.
2021-07-29
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20210221789 - Bruncko; Milan ;   et al.
2021-07-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200345717 - WANG; Le ;   et al.
2020-11-05
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200325153 - Judd; Andrew S. ;   et al.
2020-10-15
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200253954 - Kind Code
2020-08-13
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20200246460 - Kind Code
2020-08-06
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20200239553 - Ackler; Scott L. ;   et al.
2020-07-30
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20200231566 - Bruncko; Milan ;   et al.
2020-07-23
Macrocyclic MCL-1 inhibitors and methods of use
Grant 10,676,485 - Judd , et al.
2020-06-09
Macrocyclic MCL-1 Inhibitors and Methods of Use
App 20200010480 - Brady; Patrick B. ;   et al.
2020-01-09
Macrocyclic MCL-1 inhibitors and methods of use
App 20190144465 - Judd; Andrew S. ;   et al.
2019-05-16
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20190142941 - Ackler; Scott L. ;   et al.
2019-05-16
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20190119247 - Bruncko; Milan ;   et al.
2019-04-25
Macrocyclic MCL-1 inhibitors and methods of use
App 20190055264 - Brady; Patrick B. ;   et al.
2019-02-21
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180251426 - Bruncko; Milan ;   et al.
2018-09-06
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180221363 - WANG; Le ;   et al.
2018-08-09
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20180140595 - Wang; Le ;   et al.
2018-05-24
Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,877,958 - Wang , et al. January 30, 2
2018-01-30
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,844,547 - Wang , et al. December 19, 2
2017-12-19
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20170296531 - Wang; Le ;   et al.
2017-10-19
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20170158666 - Bruncko; Milan ;   et al.
2017-06-08
Pyridinone and pyridazinone derivatives
Grant 9,561,231 - Hubbard , et al. February 7, 2
2017-02-07
BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
App 20160339117 - Ackler; Scott L. ;   et al.
2016-11-24
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160304451 - Elmore; Steven W. ;   et al.
2016-10-20
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160206611 - Wang; Le ;   et al.
2016-07-21
BCL-XL Inhibitory Compounds and Antibody Drug Conjugates Including the Same
App 20160158377 - Ackler; Scott L. ;   et al.
2016-06-09
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160158218 - Wang; Le ;   et al.
2016-06-09
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,315,488 - Ding , et al. April 19, 2
2016-04-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,303,025 - Bruncko , et al. April 5, 2
2016-04-05
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,266,877 - Wang , et al. February 23, 2
2016-02-23
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20160009687 - Ding; Hong ;   et al.
2016-01-14
Apoptosis-inducing Agent For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20160002187 - Kunzer; Aaron R. ;   et al.
2016-01-07
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,227,963 - Wang , et al. January 5, 2
2016-01-05
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150329541 - Bruncko; Milan ;   et al.
2015-11-19
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,174,982 - Bruncko , et al. November 3, 2
2015-11-03
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 9,156,856 - Kunzer , et al. October 13, 2
2015-10-13
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,125,913 - Bruncko , et al. September 8, 2
2015-09-08
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,073,855 - Doherty , et al. July 7, 2
2015-07-07
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,072,748 - Bruncko , et al. July 7, 2
2015-07-07
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150183775 - BRUNCKO; Milan ;   et al.
2015-07-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150152097 - Wang; Le ;   et al.
2015-06-04
Apoptosis promoters
Grant 9,045,444 - Ding , et al. June 2, 2
2015-06-02
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 9,045,420 - Doherty , et al. June 2, 2
2015-06-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20150072978 - Wang; Le ;   et al.
2015-03-12
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,952,157 - Ding , et al. February 10, 2
2015-02-10
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,940,737 - Wang , et al. January 27, 2
2015-01-27
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,889,675 - Wang , et al. November 18, 2
2014-11-18
Apoptosis Promoters
App 20140187531 - Bruncko; Milan ;   et al.
2014-07-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140113910 - Bruncko; Milan ;   et al.
2014-04-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140107119 - Bruncko; Milan ;   et al.
2014-04-17
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140094471 - Bruncko; Milan ;   et al.
2014-04-03
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140088106 - Bruncko; Milan ;   et al.
2014-03-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20140066621 - Bruncko; Milan ;   et al.
2014-03-06
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140057890 - Bruncko; Milan ;   et al.
2014-02-27
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20140057889 - Bruncko; Milan ;   et al.
2014-02-27
Pyridinone and Pyridazinone Derivatives
App 20130331382 - HUBBARD; Robert D. ;   et al.
2013-12-12
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 8,586,754 - Bruncko , et al. November 19, 2
2013-11-19
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20130296295 - BRUNCKO; Milan ;   et al.
2013-11-07
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
Grant 8,563,735 - Bruncko , et al. October 22, 2
2013-10-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130267534 - Bruncko; Milan ;   et al.
2013-10-10
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130267514 - Bruncko; Milan ;   et al.
2013-10-10
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,546,399 - Bruncko , et al. October 1, 2
2013-10-01
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130184278 - KUNZER; Aaron R. ;   et al.
2013-07-18
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,426,422 - Hexamer , et al. April 23, 2
2013-04-23
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130096121 - Wang; Le ;   et al.
2013-04-18
Apoptosis-induced Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20130096120 - WANG; LE ;   et al.
2013-04-18
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,343,967 - Ding , et al. January 1, 2
2013-01-01
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,338,466 - Kunzer , et al. December 25, 2
2012-12-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20120214796 - Ding; Hong ;   et al.
2012-08-23
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20120190688 - Bruncko; Milan ;   et al.
2012-07-26
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
Grant 8,188,077 - Ding , et al. May 29, 2
2012-05-29
Apoptosis promoters
Grant 8,084,607 - Bruncko , et al. December 27, 2
2011-12-27
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20110237553 - Ding; Hong ;   et al.
2011-09-29
Biaryl carboxylic acid apoptosis promoters
Grant 7,989,656 - Wendt , et al. August 2, 2
2011-08-02
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20110124628 - Bruncko; Milan ;   et al.
2011-05-26
Survivin inhibitors
Grant 7,910,742 - Wendt , et al. March 22, 2
2011-03-22
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100305122 - Bruncko; Milan ;   et al.
2010-12-02
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20100298321 - Bruncko; Milan ;   et al.
2010-11-25
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100298323 - Bruncko; Milan ;   et al.
2010-11-25
Apoptosis Promoters
App 20100234456 - Wendt; Michael D. ;   et al.
2010-09-16
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100184750 - Hexamer; Laura A. ;   et al.
2010-07-22
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100184766 - Kunzer; Aaron R. ;   et al.
2010-07-22
N-acylsulfonamide apoptosis promoters
Grant 7,754,886 - Augeri , et al. July 13, 2
2010-07-13
Apoptosis promoters
Grant 7,750,004 - Wendt , et al. July 6, 2
2010-07-06
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases
App 20100160322 - Bruncko; Milan ;   et al.
2010-06-24
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases
App 20100152183 - Bruncko; Milan ;   et al.
2010-06-17
N-acylsulfonamide Apoptosis Promoters
App 20090137585 - Augeri; David J. ;   et al.
2009-05-28
N-acylsulfonamide apoptosis promoters
Grant 7,504,512 - Augeri , et al. March 17, 2
2009-03-17
Apoptosis promoters
App 20070135392 - Wendt; Michael D. ;   et al.
2007-06-14
Survivin inhibitors
App 20070072833 - Wendt; Michael D. ;   et al.
2007-03-29
N-acylsulfonamide apoptosis promoters
App 20040192681 - Augeri, David J. ;   et al.
2004-09-30
N-acylsulfonamide apoptosis promoters
Grant 6,720,338 - Augeri , et al. April 13, 2
2004-04-13
N-Acylsulfonamide apoptosis promoters
App 20020086887 - Augeri, David J. ;   et al.
2002-07-04
N-acylsulfonamide apoptosis promoters
App 20020055631 - Augeri, David J. ;   et al.
2002-05-09
Urokinase inhibitors
App 20010049374 - Steele, Andrew W. ;   et al.
2001-12-06
Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adrenergic compounds
Grant 6,046,207 - Meyer , et al. April 4, 2
2000-04-04
Benzopyranopyrrole and benzopyranopyridine .alpha.-1 adenergic compounds
Grant 5,891,882 - Meyer , et al. April 6, 1
1999-04-06
Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
Grant 5,597,823 - Meyer , et al. January 28, 1
1997-01-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed